Pernelle Lavaud

Villejuif, 94805, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Validation of the lung immune prognostic index in extensive-stage small cell lung cancer: Post hoc analysis of the caspian and IMpower133 phase 3 trials.

Validation of the lung immune prognostic index in extensive-stage small cell lung cancer: Post hoc analysis of the caspian and IMpower133 phase 3 trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 29, 2026

Outcomes and Treatments of Patients With Non-Small Cell Lung Cancer Who Received Pembrolizumab.

Outcomes and Treatments of Patients With Non-Small Cell Lung Cancer Who Received Pembrolizumab.

Journal: JAMA oncology

Published: April 09, 2026

Safety and efficacy of concurrent radiation therapy with amivantamab in patients with advanced EGFR- or MET-altered non-small cell lung cancer.

Safety and efficacy of concurrent radiation therapy with amivantamab in patients with advanced EGFR- or MET-altered non-small cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 12, 2026

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Journal: Clinical lung cancer

Published: January 11, 2026

Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC).

Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC).

Journal: ESMO open

Published: December 31, 2025

Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?

Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 09, 2025

Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer.

Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer.

Journal: JAMA network open

Published: September 10, 2025

Impact of tumour volume on outcomes in patients with locally advanced non-small cell lung cancer receiving chemoradiotherapy and consolidation durvalumab.

Impact of tumour volume on outcomes in patients with locally advanced non-small cell lung cancer receiving chemoradiotherapy and consolidation durvalumab.

Journal: The British journal of radiology

Published: May 27, 2025

Efficacy and cost-effectiveness of lung cancer screening in France with low-dose computed tomography.

Efficacy and cost-effectiveness of lung cancer screening in France with low-dose computed tomography.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: May 20, 2025

Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.

Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.

Journal: Cancer discovery

Published: December 03, 2024

Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study.

Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study.

Journal: Journal for immunotherapy of cancer

Published: November 25, 2024

Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer.

Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer.

Journal: Nature communications

Published: October 31, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026